Skip to content

The effect of mindfulness group therapy on a broad range of psychiatric symptoms: A randomised controlled trial in primary health care

Jan Sundquist, Karolina Palmér, Lars-Åke Johansson, Kristina Sundquist

European Psychiatry February 8, 2017 DOI: 10.1016/j.eurpsy.2017.01.328 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Peer reviewed
Sample size 215
Population Men and women aged 20-64 with depressive, anxiety and/or stress and adjustment disorders in primary care
Intervention Mindfulness-based group therapy
Duration 8-week intervention with 8-week follow-up
Measures Symptom Checklist-90 (SCL-90), Mindful Attention Awareness Scale (MAAS)
Topics Meditation
Citations 40
Registration NCT01476371
Key findings Both mindfulness-based group therapy and treatment as usual (mainly individual cognitive behavioral therapy) produced significant improvements across all SCL-90 subscales and indexes and increased mindful attention awareness, with no significant difference between groups in psychiatric symptom change. The mindfulness group had a somewhat larger improvement on the MAAS, but this was non-significant (P=0.06). The authors conclude both therapies could be used in primary care, with group therapy potentially saving limited resources.

Abstract

Background: The need for psychotherapy in primary health care is on the increase but individual-based treatment is costly. The main aim of this randomised controlled trial (RCT) was to compare the effect of mindfulness-based group therapy (MGT) with treatment as usual (TAU), mainly individual-based cognitive behavioural therapy (CBT), on a broad range of psychiatric symptoms in primary care patients diagnosed with depressive, anxiety and/or stress and adjustment disorders. An additional aim was to compare the effect of MGT with TAU on mindful attention awareness.

Methods: This 8-week RCT took place in 2012 at 16 primary care centres in southern Sweden. The study population included both men and women, aged 20-64years (n=215). A broad range of psychiatric symptoms were evaluated at baseline and at the 8-week follow-up using the Symptom Checklist-90 (SCL-90). Mindful attention awareness was also evaluated using the Mindful Attention Awareness Scale (MAAS).

Results: In both groups, the scores decreased significantly for all subscales and indexes in SCL-90, while the MAAS scores increased significantly. There were no significant differences in the change in psychiatric symptoms between the two groups. The mindfulness group had a somewhat larger change in scores than the control group on the MAAS (P=0.06, non-significant).

Conclusions: No significant differences between MGT and TAU, mainly individual-based CBT, were found in treatment effect. Both types of therapies could be used in primary care patients with depressive, anxiety and/or stress and adjustment disorders, where MGT has a potential to save limited resources.

Trial Registration: ClinicalTrials.gov identifier: NCT01476371.

Comparable studies

Other randomized controlled trials on meditation, most cited first.

Study Year Design Participants
Alterations in Brain and Immune Function Produced by Mindfulness Meditation Healthy employees in a work environment 2003 Randomized controlled trial n = 41
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Open hearts build lives: Positive emotions, induced through loving-kindness meditation, build consequential personal resources. Working adults 2008 Randomized controlled trial n = 139
Short-term meditation training improves attention and self-regulation Undergraduate Chinese students 2007 Randomized controlled trial n = 40
Mindfulness-Based Cognitive Therapy for Depression: Replication and Exploration of Differential Relapse Prevention Effects. Recovered recurrently depressed patients 2004 Randomized controlled trial n = 73

Citations in the library

Explore topics